Vimarsana
Biggest News Aggregation in the World

Page 9 - Sanofi Pasteur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanofi Pasteur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanofi Pasteur Today - Breaking & Trending Today

Dengue Rages Around The Globe. Where Are The Vaccines? - Vimarsana News

Dengue Rages Around The Globe. Where Are The Vaccines?

Dengue is spreading even in temperate climates like the U.S. and Europe. Learn about the threat and the difficult journey to make a safe and effective vaccine.

Source: forbes.com
French Pacific news in brief - Vimarsana News

French Pacific news in brief

A round-up of news in brief from the French Pacific region, including a strike by employees of the only petrol retail company in Wallis and Futuna causing all service stations to run dry.

Source: rnz.co.nz
Dengue Fever Outbreak In Brazil: What To Know About The 'Breakbone Fever' Virus Soaring Globally - Vimarsana News

Dengue Fever Outbreak In Brazil: What To Know About The 'Breakbone Fever' Virus Soaring Globally

Dengue, also known as breakbone fever, is spread through the bites of mosquitoes common throughout much of the United States.

Source: forbes.com
EMA to investigate HPV vaccine for severe side effects, complex regional pain syndrome and postural orthostatic tachycardia syndrome - Vimarsana News

EMA to investigate HPV vaccine for severe side effects, complex regional pain syndrome and postural orthostatic tachycardia syndrome

July 13, 2015 | By Eric Sagonowsky While the European Medicines Agency said it "does not question that the benefits of HPV vaccines outweigh their risks," on Monday it announced a safety review of the shots that have thus far failed to live up to expectations partly due to safety concerns and a sex-related stigma.…

CA junks Sanofi's plea to rule on validity of revocation of its CPR for Dengvaxia - Vimarsana News

CA junks Sanofi's plea to rule on validity of revocation of its CPR for Dengvaxia

THE Court of Appeals has turned down the plea of pharmaceutical company Sanofi Pasteur Inc. (SPI) to rule on the merit of its petition assailing the government’s decision to revoke its certificates of product registration (CPR) for the controversial Dengvaxia, a vaccine used for protection against dengue disease.  In a 19-page decision penned…